CN105705025B - 包含十八碳四烯酸和橄榄油的食用脂质组合物 - Google Patents

包含十八碳四烯酸和橄榄油的食用脂质组合物 Download PDF

Info

Publication number
CN105705025B
CN105705025B CN201480055348.9A CN201480055348A CN105705025B CN 105705025 B CN105705025 B CN 105705025B CN 201480055348 A CN201480055348 A CN 201480055348A CN 105705025 B CN105705025 B CN 105705025B
Authority
CN
China
Prior art keywords
lipid composition
sda
oil
olive oil
epa
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201480055348.9A
Other languages
English (en)
Chinese (zh)
Other versions
CN105705025A (zh
Inventor
哈尔门·霍夫斯特拉
厄尔扬·塞勒
奥拉·艾德
琳达·克里斯蒂娜·萨加
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Saele Invest & Consulting AS
Original Assignee
Saele Invest & Consulting AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Saele Invest & Consulting AS filed Critical Saele Invest & Consulting AS
Publication of CN105705025A publication Critical patent/CN105705025A/zh
Application granted granted Critical
Publication of CN105705025B publication Critical patent/CN105705025B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
    • A23D9/00—Other edible oils or fats, e.g. shortenings or cooking oils
    • A23D9/007—Other edible oils or fats, e.g. shortenings or cooking oils characterised by ingredients other than fatty acid triglycerides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
    • A23D9/00—Other edible oils or fats, e.g. shortenings or cooking oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
    • A23D9/00—Other edible oils or fats, e.g. shortenings or cooking oils
    • A23D9/007—Other edible oils or fats, e.g. shortenings or cooking oils characterised by ingredients other than fatty acid triglycerides
    • A23D9/013—Other fatty acid esters, e.g. phosphatides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/306—Foods, ingredients or supplements having a functional effect on health having an effect on bone mass, e.g. osteoporosis prevention
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/308—Foods, ingredients or supplements having a functional effect on health having an effect on cancer prevention
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/31—Foods, ingredients or supplements having a functional effect on health having an effect on comfort perception and well-being
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/322—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the nervous system or on mental function
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/326—Foods, ingredients or supplements having a functional effect on health having effect on cardiovascular health
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/328—Foods, ingredients or supplements having a functional effect on health having effect on glycaemic control and diabetes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Hospice & Palliative Care (AREA)
CN201480055348.9A 2013-10-07 2014-10-07 包含十八碳四烯酸和橄榄油的食用脂质组合物 Active CN105705025B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP13187560 2013-10-07
EP13187560.1 2013-10-07
PCT/EP2014/071418 WO2015052171A1 (en) 2013-10-07 2014-10-07 Edible lipid composition comprising stearidonic acid and olive oil

Publications (2)

Publication Number Publication Date
CN105705025A CN105705025A (zh) 2016-06-22
CN105705025B true CN105705025B (zh) 2020-06-23

Family

ID=49301375

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201480055348.9A Active CN105705025B (zh) 2013-10-07 2014-10-07 包含十八碳四烯酸和橄榄油的食用脂质组合物

Country Status (15)

Country Link
US (1) US20160227808A1 (enExample)
EP (1) EP3054777B1 (enExample)
JP (1) JP6506746B2 (enExample)
KR (1) KR102373207B1 (enExample)
CN (1) CN105705025B (enExample)
AU (1) AU2014333878B2 (enExample)
CA (1) CA2924265C (enExample)
DK (1) DK3054777T3 (enExample)
EA (1) EA028641B1 (enExample)
ES (1) ES2672313T3 (enExample)
HU (1) HUE037991T2 (enExample)
LT (1) LT3054777T (enExample)
NO (1) NO3054777T3 (enExample)
PL (1) PL3054777T3 (enExample)
WO (1) WO2015052171A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10846257B2 (en) 2014-04-01 2020-11-24 Endance Technology Limited Intelligent load balancing and high speed intelligent network recorders
CN108402466A (zh) * 2017-02-10 2018-08-17 台湾原生药用植物股份有限公司 含不饱和脂肪酸的素食组合物
JP6901274B2 (ja) * 2017-02-14 2021-07-14 株式会社ファンケル ω３系脂肪酸吸収促進用組成物
US11638440B2 (en) * 2017-02-28 2023-05-02 Cg-Bio Genomics, Inc. Healthful supplement food
US20240091110A1 (en) * 2019-10-07 2024-03-21 Colgate-Palmolive Company Oral Care Compositions and Methods of Use
KR102748655B1 (ko) * 2021-12-20 2025-01-02 씨제이제일제당 (주) 스쿠알렌 및 토코페롤을 포함하는 유지의 색가 안정용 조성물

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101677589A (zh) * 2007-01-03 2010-03-24 孟山都技术有限公司 掺入十八碳四烯酸的食品组合物
CN102469825A (zh) * 2009-06-30 2012-05-23 索莱有限责任公司 富含ω-3脂肪酸的烘焙食品和棒组合物
CN102469826A (zh) * 2009-07-15 2012-05-23 索莱有限责任公司 富含ω-3脂肪酸的汤和调味料
AU2012100994A8 (en) * 2012-06-30 2012-08-02 Hinson, Brian Mr Hempseed/olive oil and waste blending
CN102843913A (zh) * 2010-02-17 2012-12-26 邦奇油类公司 十八碳四烯酸的油组合物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2150741A1 (en) * 1994-06-17 1995-12-18 Susan Trimbo Pediatric lipid emulsion
ES2202454T3 (es) * 1995-07-04 2004-04-01 Suntory Limited Uso de un agente equilibrante para acidos grasos insaturados omega-3 y omega-6.
JP3466014B2 (ja) * 1995-12-25 2003-11-10 交洋ファインケミカル株式会社 植物性スクワラン濃縮物の製造方法
JP2000104092A (ja) * 1998-09-29 2000-04-11 Nof Corp 血清脂質改善油脂組成物
JP2007056181A (ja) * 2005-08-26 2007-03-08 Toyo Olive Co Ltd 機能性オリーブ油、その製造方法およびその用途
JP4904751B2 (ja) * 2005-09-14 2012-03-28 株式会社カネカ 生体内ｄｈａ合成促進剤
ES2289897B1 (es) * 2005-11-08 2008-12-16 Laboratorios Belmac, S.A. Composicion para administracion transdermica de agentes fisiologicamente activos.
BRPI0708535A2 (pt) * 2006-03-03 2011-05-31 Monsanto Technology Llc meios para melhora da saúde cardiovascular
US20090099261A1 (en) * 2007-09-25 2009-04-16 Isi Brands Inc. Omega-3 mixtures
FR2948025B1 (fr) * 2009-07-15 2013-01-11 Univ Grenoble 1 Composition comprenant un polyphenol et un acide gras omega-3

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101677589A (zh) * 2007-01-03 2010-03-24 孟山都技术有限公司 掺入十八碳四烯酸的食品组合物
CN102469825A (zh) * 2009-06-30 2012-05-23 索莱有限责任公司 富含ω-3脂肪酸的烘焙食品和棒组合物
CN102469826A (zh) * 2009-07-15 2012-05-23 索莱有限责任公司 富含ω-3脂肪酸的汤和调味料
CN102843913A (zh) * 2010-02-17 2012-12-26 邦奇油类公司 十八碳四烯酸的油组合物
AU2012100994A8 (en) * 2012-06-30 2012-08-02 Hinson, Brian Mr Hempseed/olive oil and waste blending

Also Published As

Publication number Publication date
EA028641B1 (ru) 2017-12-29
KR102373207B1 (ko) 2022-03-11
EP3054777B1 (en) 2018-03-07
HUE037991T2 (hu) 2018-09-28
PL3054777T3 (pl) 2018-10-31
KR20160065903A (ko) 2016-06-09
CA2924265A1 (en) 2015-04-16
NO3054777T3 (enExample) 2018-08-04
US20160227808A1 (en) 2016-08-11
EA201690692A1 (ru) 2016-07-29
WO2015052171A1 (en) 2015-04-16
LT3054777T (lt) 2018-07-10
CA2924265C (en) 2019-12-24
AU2014333878A2 (en) 2016-04-21
AU2014333878A1 (en) 2016-04-14
CN105705025A (zh) 2016-06-22
AU2014333878B2 (en) 2017-12-07
ES2672313T3 (es) 2018-06-13
JP6506746B2 (ja) 2019-04-24
DK3054777T3 (en) 2018-06-14
EP3054777A1 (en) 2016-08-17
JP2016533716A (ja) 2016-11-04

Similar Documents

Publication Publication Date Title
Stuchlík et al. Vegetable lipids as components of functional foods
Bester et al. Cardiovascular effects of edible oils: a comparison between four popular edible oils
JP7007010B2 (ja) 脂質含有組成物およびその使用方法
Oguntibeju et al. Red palm oil: nutritional, physiological and therapeutic roles in improving human wellbeing and quality of life
Enig Coconut: in support of good health in the 21st century
CA2924265C (en) Edible lipid composition comprising stearidonic acid and olive oil
AU716372B2 (en) Food composition containing an omega-6/omega-3 unsaturated fatty acid balance modifier
KR20120115965A (ko) 안구 건조의 완화를 위한 영양 보충제
CN103891924A (zh) 一种含玉米油的调和油及其制备方法
Asif Chemical characteristics and nutritional potentials of unsaturated fatty acids
CN108402188A (zh) 一种强化补充DHA和α-亚麻酸的食用油及制备方法
Vázquez et al. Bioactive lipids
Salsinha et al. Bioactive lipids: Chemistry, biochemistry, and biological properties
US8691293B2 (en) Low inflammatory blended oils
Aluko Bioactive lipids
CA3069902A1 (en) Compositions comprising thymoquinone and omega-3 fatty acids
ES2413497B1 (es) Composición con alto contenido en Omega 3, Omega 6 y Omega 9
Suroowan et al. Olive and olive oil: a one stop herbal solution for the prophylaxis and management of cardiovascular disorders
HK1227637A1 (en) Edible lipid composition comprising stearidonic acid and olive oil
HK1227637B (en) Edible lipid composition comprising stearidonic acid and olive oil
AU2016361585A1 (en) Composition of olivetol and method of use reduce or inhibit the effects of tetrahydrocannabinol in the human body
Kengne et al. Investigation of the antihyperlipidemic property of Raphia hookeri mesocarp oil in high-lard diet (HLD) fed rats
CN110050847A (zh) 一种生酮饮食和脂肪酸混合食用植物调和油
Waly Mediterranean foods and human health
AU2021249347A1 (en) Composition for improving friendliness and/or empathetic capacity

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant